The path ahead is looking a bit brighter for this pharmaceutical company.
News & Analysis: TherapeuticsMD, Inc.
August sales figures suggest the company's strategy is working.
The women’s health expert logged a solid second quarter.
Investors are cheering second-quarter results that were better than expected, and an improved outlook for the year.
TXMD earnings call for the period ending June 30, 2019.
The women's health company reported first-quarter 2019 operating results.
TXMD earnings call for the period ending March 31, 2019.
Are intrepid short-sellers taking advantage of misguided enthusiasm?
TXMD earnings call for the period ending December 31, 2018.
The company impressed investors with more encouraging sales figures for its recently launched dyspareunia treatment.